ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för sodium valproate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

27 träffar

Bibliografisk träff 2024-05-06

Simultaneous, Dual Continuous Venovenous Haemodiafiltration as Salvage Therapy for Severe Sodium Valproate Intoxication.

Hussan A, Hasan I, El-Hayani R, Zahra MS.

Case Rep Crit Care · journal article; case reports; case-report · DOI 10.1155/2024/2712480

Bibliografisk träff 2024-04-19

Retrospective Analysis of Steady-State Sodium Valproate Plasma Concentrations in Chinese Patients With Bipolar Disorder: Impact of Demographic and Clinical Characteristics.

Qiming Q, Ping Z, Huiqi L, Leyu X, LIren L, Ming L.

Ther Drug Monit · research support, non-u.s. gov't; research-article; journal article · DOI 10.1097/ftd.0000000000001199

Bibliografisk träff 2024-03-27

Comparison of the efficacy and safety of sodium valproate versus levetiracetam in the treatment of severe traumatic brain injury.

Huang X, Lin W, Wang J, Liu C, Wei G, Wang J, Wang C.

Int J Neurosci · comparative study; randomized controlled trial; journal article · DOI 10.1080/00207454.2024.2332959

Bibliografisk träff 2024-03-05

Subcutaneous sodium valproate in palliative care: A systematic review.

Tan S, Ng JS, Tang C, Stretton B, Kovoor J, Gupta A, Delloso T, Zhang T, Goh R, El-Masri S, Kiley M, Maddocks I, Harroud A, Stacpoole S, Crawford G, Bacchi S.

Palliat Med · research-article; systematic review; journal article · DOI 10.1177/02692163241234597

Bibliografisk träff 2024-03-05

Effect of duration of sodium valproate therapy on bone mineral density and vitamin D levels.

Nirmal D, Abdul S, Jaiswal P, Naunihal Singh S, Avaragollapuravarga Mathada A, Nagaraj P.

Epilepsy Behav · journal article · DOI 10.1016/j.yebeh.2024.109733

Bibliografisk träff 2024-03-02

Sodium valproate treatment reverses endothelial dysfunction in aorta from rabbits with acute myocardial infarction.

Guerra-Ojeda S, Suarez A, Belmonte B, Marchio P, Genovés P, Arias OJ, Aldasoro M, Vila JM, Serna E, Mauricio MD.

Eur J Pharmacol · journal article · DOI 10.1016/j.ejphar.2024.176475

Bibliografisk träff 2024-02-08

Effects of sodium valproate and levetiracetam on posterior segment parameters in children with epilepsy.

Sahin AK, Cirakli S.

Int Ophthalmol · journal article · DOI 10.1007/s10792-024-02987-0

Bibliografisk träff 2024-01-10

Agony of akathisia: a case of sodium valproate-induced akathisia.

Lim G, Tang A, Wing T, Lai J.

BMJ Case Rep · journal article; case reports; case-report · DOI 10.1136/bcr-2023-255427

Bibliografisk träff 2024-01-08

Sodium valproate for severe neuropathic pain in advanced cancer.

Crispin H.

BMJ Support Palliat Care · letter · DOI 10.1136/spcare-2023-004259

Bibliografisk träff 2024-01-03

Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study.

Mogawer RM, Fawzy MM, Mourad A, Ahmed H, Nasr M, Nour ZA, Hafez V.

Arch Dermatol Res · research-article; randomized controlled trial; journal article · DOI 10.1007/s00403-023-02785-1

Bibliografisk träff 2023-11-30

Unusual case of sodium valproate-induced hyperammonaemia encephalopathy.

Ranjith S, Abeysundera H, Jeyaranjan H.

BMJ Case Rep · journal article; case reports; case-report · DOI 10.1136/bcr-2023-256796

Bibliografisk träff 2023-11-30

Preclinical Study in Mouse Thymus and Thymocytes: Effects of Treatment with a Combination of Sodium Dichloroacetate and Sodium Valproate on Infectious Inflammation Pathways.

Stakišaitis D, Kapočius L, Kilimaitė E, Gečys D, Šlekienė L, Balnytė I, Palubinskienė J, Lesauskaitė V.

Pharmaceutics · research-article; journal article · DOI 10.3390/pharmaceutics15122715

Bibliografisk träff 2023-11-21

Sodium valproate: cacosmia and dysgeusia as uncommon side effects.

Montalbano C, Raia A, Caruso V, Migli L.

Arch Clin Cases · journal article; case reports; case-report · DOI 10.22551/2023.41.1004.10265

Bibliografisk träff 2023-11-15

Effect of dietary supplementation with Lactobacillus helveticus R0052 on seizure thresholds and antiseizure potency of sodium valproate in mice.

Wlaź P, Wiater A, Majewska M, Wyska E, Grąz M, Śliwa-Dominiak J, Gapińska N, Socała K.

Psychopharmacology (Berl) · research-article; journal article · DOI 10.1007/s00213-023-06489-2

Bibliografisk träff 2023-11-14

Akkermansia muciniphila MucT attenuates sodium valproate-induced hepatotoxicity and upregulation of Akkermansia muciniphila in rats.

Cui Z, Xu L, Zhao M, Zhou L.

J Cell Mol Med · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/jcmm.18026

Bibliografisk träff 2023-11-06

Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar-I disorder: A double-blind, randomized, placebo-controlled clinical trial.

Zandifar A, Badrfam R, Gholamian F, Shafiee A.

Brain Behav · research support, non-u.s. gov't; research-article; randomized controlled trial; journal article · DOI 10.1002/brb3.3313

Bibliografisk träff 2023-10-26

Comparing Prophylactic Effect of Levetiracetam, Sodium Valproate, and Propranolol in Pediatric Migraine: A Randomized Clinical Trial.

Fayyazi A, Pezeshki N, Mansuri H, Khajeh A.

Iran J Child Neurol · research-article; journal article · DOI 10.22037/ijcn.v17i1.21330

Bibliografisk träff 2023-09-13

Sodium Valproate Use in Japanese Patients with Schizophrenia and Coronavirus Disease Is Associated with an Increased Risk of Pneumonia.

Arai Y, Sasayama D, Kuraishi A, Sahara R, Murata S, Tanaka A, Amemiya K, Usuda N, Kuraishi K, Washizuka S.

J Clin Med · research-article; journal article · DOI 10.3390/jcm12185953

Bibliografisk träff 2023-08-02

Sodium Valproate-Induced Hyperpigmentation.

Elwadhi A, Neha KC, Gupta D, Sharawat IK, Panda PK.

J Pediatr · journal article; case reports · DOI 10.1016/j.jpeds.2023.113660

Bibliografisk träff 2023-07-07

Unconditioned and conditioned anxiolytic effects of Sodium Valproate on flavor neophobia and fear conditioning.

Cintado MÁ, González G, Cárcel L, De la Casa LG.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0279511

Bibliografisk träff 2023-07-01

Comparing Pregabalin and Sodium Valproate in Pediatric Migraine Prophylaxis: A Randomized Clinical Trial.

Jafari N, Nasehi MM, Nasiri Eghbali A, Taghdiri MM, Karimzadeh P.

Iran J Child Neurol · research-article; journal article · DOI 10.22037/ijcn.v17i2.36175

Bibliografisk träff 2023-04-07

Minimum effective sodium valproate dose in genetic generalized epilepsies.

Marques VD, Hackbart BA, Guilhoto LM, Duarte JTC, Peixoto-Santos JE, Yacubian EMT, Bittar Guaranha MS.

Seizure · journal article; observational study · DOI 10.1016/j.seizure.2023.04.009

Bibliografisk träff 2022-06-30

Evaluation of the Effect of Alcoholic Extract of <i>Laurus Nobilis</i> Leaves on Blood Biochemical Parameters and Histological Changes in the Liver and Kidney among Female Wistar Rats Treated with Depakene (Sodium Valproate).

Shnewer Mahdi Al-Turfi Z, Al-Hadrawy SMJ, Abadi Mohammed J, Chasib Jabal B.

Arch Razi Inst · research-article; journal article · DOI 10.22092/ari.2022.357272.2011

Bibliografisk träff 2009-11-01

Sodium valproate and the fetus: a case study and review of the literature.

Smith J, Whitehall J.

Neonatal Netw · review; journal article; case reports · DOI 10.1891/0730-0832.28.6.363

Bibliografisk träff 2008-12-09

Sodium valproate, a histone deacetylase inhibitor, decreases the secretion of soluble Fas by human osteosarcoma cells and increases their sensitivity to Fas-mediated cell death.

Yamanegi K, Yamane J, Hata M, Ohyama H, Yamada N, Kato-Kogoe N, Futani H, Nakasho K, Okamura H, Terada N.

J Cancer Res Clin Oncol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s00432-008-0522-z

Bibliografisk träff 2008-06-01

[Sodium valproate synergizes adriamycin to inhibit proliferation and induce apoptosis in myelodysplastic syndrome cell line].

Yu C, Chen BA, Gao C, Ding JH, Xia GH, Shao ZY, Gao F, Sun YY, Cheng J, Zhao G, Wang J, Song HH, Ma Y, Bao W.

Zhongguo Shi Yan Xue Ye Xue Za Zhi · research support, non-u.s. gov't; journal article; english abstract

Bibliografisk träff 2008-01-29

Valproic acid extends Caenorhabditis elegans lifespan.

Evason K, Collins JJ, Huang C, Hughes S, Kornfeld K.

Aging Cell · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1111/j.1474-9726.2008.00375.x